These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 8452322)

  • 1. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.
    Ravid M; Savin H; Jutrin I; Bental T; Katz B; Lishner M
    Ann Intern Med; 1993 Apr; 118(8):577-81. PubMed ID: 8452322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.
    Ravid M; Brosh D; Levi Z; Bar-Dayan Y; Ravid D; Rachmani R
    Ann Intern Med; 1998 Jun; 128(12 Pt 1):982-8. PubMed ID: 9625684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
    Ravid M; Lang R; Rachmani R; Lishner M
    Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
    Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
    Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
    Ahmad J; Siddiqui MA; Ahmad H
    Diabetes Care; 1997 Oct; 20(10):1576-81. PubMed ID: 9314638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effect of ACE inhibition on development of nephropathy in diabetes mellitus type II.
    Ravid M; Savin H; Jutrin I; Bental T; Lang R; Lishner M
    Kidney Int Suppl; 1994 Feb; 45():S161-4. PubMed ID: 8158887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive type 2 diabetic patients: results of a 4-year, prospective, randomized study.
    Sano T; Hotta N; Kawamura T; Matsumae H; Chaya S; Sasaki H; Nakayama M; Hara T; Matsuo S; Sakamoto N
    Diabet Med; 1996 Feb; 13(2):120-4. PubMed ID: 8641115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
    Marre M; Chatellier G; Leblanc H; Guyene TT; Menard J; Passa P
    BMJ; 1988 Oct; 297(6656):1092-5. PubMed ID: 2848604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent albuminuria in normotensive non-insulin-dependent (type II) diabetic patients: comparative effects of angiotensin-converting enzyme inhibitors and beta-adrenoceptor blockers.
    Stornello M; Valvo EV; Scapellato L
    Clin Sci (Lond); 1992 Jan; 82(1):19-23. PubMed ID: 1310913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibition in normotensive type II diabetics with persistent mild proteinuria.
    Stornello M; Valvo EV; Scapellato L
    J Hypertens Suppl; 1989 Dec; 7(6):S314-5. PubMed ID: 2561147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.
    Heinemann L; Janicke I; Bender R; Berger M; Sawicki PT
    Horm Metab Res; 1996 Oct; 28(10):549-52. PubMed ID: 8934214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
    Laffel LM; McGill JB; Gans DJ
    Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.
    Schrier RW; Estacio RO; Esler A; Mehler P
    Kidney Int; 2002 Mar; 61(3):1086-97. PubMed ID: 11849464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipids and the progression of nephropathy in diabetes mellitus type II: effect of ACE inhibitors.
    Ravid M; Neumann L; Lishner M
    Kidney Int; 1995 Mar; 47(3):907-10. PubMed ID: 7752591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes.
    Hallab M; Gallois Y; Chatellier G; Rohmer V; Fressinaud P; Marre M
    BMJ; 1993 Jan; 306(6871):175-82. PubMed ID: 8443481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
    Andersen S; Tarnow L; Rossing P; Hansen BV; Parving HH
    Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary albumin excretion in non-insulin-dependent diabetic patients. Effects of an angiotensin-converting enzyme inhibitor].
    Durruty P; Tapia JC; Ugarte C; Pérez E; Krause P; Soto N; García de los Ríos M
    Rev Med Chil; 1996 Sep; 124(9):1036-44. PubMed ID: 9197016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM.
    Crepaldi G; Carta Q; Deferrari G; Mangili R; Navalesi R; Santeusanio F; Spalluto A; Vanasia A; Villa GM; Nosadini R
    Diabetes Care; 1998 Jan; 21(1):104-10. PubMed ID: 9538979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.
    Barnett AH; Bain SC; Bouter P; Karlberg B; Madsbad S; Jervell J; Mustonen J;
    N Engl J Med; 2004 Nov; 351(19):1952-61. PubMed ID: 15516696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.